DANBURY, Conn., Feb. 15 /PRNewswire-FirstCall/ -- Penwest Pharmaceuticals Co. (NASDAQ:PPCO) will conduct a conference call on Wednesday, February 28, at 11:00 a.m. EST to review its financial results for the fourth quarter and year end of 2006, which will be released earlier that day. Operational developments and financial outlook will also be discussed on the call.
The conference call will include remarks by Jennifer Good, President and Chief Executive Officer, and Benjamin Palleiko, Senior Vice President, Corporate Development and Chief Financial Officer.
Domestic Telephone Number: 877-809-3716
International Telephone Number: 706-634-9511
The conference ID is "9092170." Please dial in 10 minutes prior to the scheduled start time. The conference call will also be accessible live and as a replay on the Investor Relations section of the Penwest Web site at http://www.penwest.com/.
Penwest Pharmaceuticals Penwest is a specialty pharmaceutical company dedicated to bringing to the marketplace innovative products that help improve the lives of patients. The Company's goal is to identify, develop and commercialize prescription products that address unmet medical needs, primarily for diseases of the nervous system. At the core of this strategy, Penwest applies drug delivery technologies, including its own proprietary technologies, to new and existing compounds to enhance their therapeutic profiles. The launch by Endo Pharmaceuticals of Opana(R) ER (oxymorphone hydrochloride extended-release tablets) in mid-2006 demonstrates the execution of this strategy and the value of Penwest's TIMERx(R) extended release delivery technology. Penwest is currently applying its expertise to a pipeline of potential products that are in various stages of development. The Company intends to commercialize these products independently and through third party alliances.
Contacts: Investors: Media:
Diane D'Alessandro Caroline Gentile/Laura Walters
(203) 796-3706 Kekst and Company
(877) 736-9378 (212) 521-4800
DATASOURCE: Penwest Pharmaceuticals CONTACT: Investors, Diane D'Alessandro, +1-203-796-3706, or +1-877-736-9378, or Media, Caroline Gentile/Laura Walters, Kekst and Company, +1-212-521-4800 Web site: http://www.penwest.com/
|